Journal of Translational Internal Medicine

(The H4-Index of Journal of Translational Internal Medicine is 14. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-02-01 to 2024-02-01.)
Potential role of ACE2 in coronavirus disease 2019 (COVID-19) prevention and management97
MiR-155 and MiR-665 role as potential non-invasive biomarkers for hepatocellular carcinoma in Egyptian patients with chronic hepatitis C virus infection41
Lung adenocarcinoma-specific three-integrin signature contributes to poor outcomes by metastasis and immune escape pathways30
Hepatic encephalopathy: Diagnosis and management29
COVID-19 and tuberculosis26
Structure and function of HECT E3 ubiquitin ligases and their role in oxidative stress25
The use of electroencephalography in patients with sepsis: A review of the literature24
Effects of des-acyl ghrelin on insulin sensitivity and macrophage polarization in adipose tissue21
The application of traditional Chinese medicine against the tumor immune escape20
Pan-cancer landscape of the RUNX protein family reveals their potential as carcinogenic biomarkers and the mechanisms underlying their action19
Pulmonary complications in patients with liver cirrhosis18
Detection of early cytokine storm in patients with septic shock after abdominal surgery16
Predicting survival for hepatic arterial infusion chemotherapy of unresectable colorectal liver metastases: Radiomics analysis of pretreatment computed tomography15
A network pharmacology approach to explore the mechanism of HuangZhi YiShen Capsule for treatment of diabetic kidney disease14
New insights of epigenetics in vascular and cellular senescence14